Newsroom

OKLAHOMA CITY--(BUSINESS WIRE)--Gulfport Energy Corporation (NYSE: GPOR) (“Gulfport” or the “Company”) today announced the successful acquisition of approximately 4,700 net undeveloped acres in the core of the Ohio Utica in Belmont County, Ohio, through the Ohio Oil and Gas Land Management Commission State Land Lease Sale for a total purchase price of approximately $83.0 million. Key Highlights Large, contiguous acquisition of approximately 4,700 net undeveloped acres secured in a highly compet...

PECHINO--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", SSE: 688796; HKEX: 02315) oggi ha annunciato di aver vinto una sentenza civile di primo grado emessa dal Tribunale per la proprietà intellettuale di Shanghai. Il tribunale ha sentenziato che Biocytogen non ha violato i relativi diritti sui brevetti rivendicati dalla parte ricorrente, Harbour Antibodies BV ("Harbour"), e ha addebitato alla parte ricorrente le spese processuali. La sentenza rappresenta un impo...

CHICAGO--(BUSINESS WIRE)--Morningstar, Inc. (Nasdaq: MORN), plans to report its second-quarter 2026 financial results after the market closes on Wednesday, July 29, 2026. The company does not hold analyst conference calls; however, investors may submit written questions to Morningstar at investors@morningstar.com. About Morningstar Morningstar, Inc. is a leading provider of independent investment insights in North America, Europe, Australia, and Asia. The Company offers an extensive line of pro...

CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) will issue its second quarter 2026 earnings release after the close of trading on the New York Stock Exchange on Wednesday, July 29, 2026. A conference call to discuss those earnings will be held on Thursday, July 30, 2026 at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). The dial-in number for the conference call is (888) 330-3576 (or +1 (646) 960-0672 for international callers), and the participant passcode is 7655497. A live webcast can b...

EWING, N.J.--(BUSINESS WIRE)--UDC today announced that Dr. Julie Brown, Executive Vice President and Chief Technical Officer, has been honored with the IEEE Frederik Philips Award....

VANCOUVER, British Columbia--(BUSINESS WIRE)--Capstone Copper Corp. (“Capstone” or the “Company”) (TSX:CS) (ASX:CSC) is pleased to announce that it has published its 2025 Sustainability Report (the “Sustainability Report” or the “Report”). The Report has been prepared in accordance with the Global Reporting Initiative (“GRI”) Standards, Sector Standard GRI 14: Mining Sector 2024, and the SASB Metals & Mining Sustainability Accounting Standard. The Report details the Company’s performance on...

COPENHAGEN, Denmark--(BUSINESS WIRE)--Genmab A/S (Nasdaq: GMAB) today announced topline results from the Phase 3 EPCORE DLBCL-4 trial evaluating the combination of fixed duration epcoritamab, a T-cell engaging bispecific antibody administered subcutaneously, and lenalidomide, compared to standard-of-care, rituximab plus gemcitabine plus oxaliplatin (R-GemOx), in adult patients with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL) who received at least one prior line of treatme...

BEIJING--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ('Biocytogen,' SSE: 688796; HKEX: 02315) heeft vandaag bekendgemaakt dat het een civielrechtelijke uitspraak in eerste aanleg heeft ontvangen van de Rechtbank voor Intellectuele Eigendom van Shanghai. De rechtbank oordeelde dat Biocytogen geen inbreuk heeft gemaakt op de relevante octrooirechten waarop eiser Harbour Antibodies BV ('Harbour') zich beriep, en veroordeelde de eiser tot het dragen van de proceskosten. Deze uit...

NEW YORK--(BUSINESS WIRE)--BNY Mellon Investment Adviser, Inc. announced today that BNY Mellon Strategic Municipal Bond Fund, Inc. and BNY Mellon Strategic Municipals, Inc. (each, a "Fund") have declared a monthly distribution for each Fund's common shares as summarized below. The distributions are payable July 31, 2026 to shareholders of record on July 14, 2026, with an ex-dividend date of July 14, 2026.     Fund     Ticker Monthly Distribution Per Share Change from Prior Monthly Distribution...

PEKÍN--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. («Biocytogen», SSE: 688796; HKEX: 02315) ha anunciado hoy que ha recibido una sentencia civil en primera instancia del Tribunal de propiedad intelectual de Shanghái. El tribunal dictaminó que Biocytogen no infringió los derechos de patente pertinentes reclamados por la parte demandante, Harbour Antibodies BV («Harbour»), y condenó a la parte demandante a asumir los costes del litigio. La sentencia supone un importante result...